Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 145-151

  McCawley, Lisa J ^a   Li, Shunan ^b   Benavidez, Mario ^c   Halbleib, Jennifer ^c   Wattenberg, Elizabeth V ^b   Hudson, Laurie G ^c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; FORSKOLIN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MORPHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033948992     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.145     Document Type: Article

References (39)

1. Barbier AJ, Poppleton HM, Yigzaw Y, Mullenix JB, Wiepz GJ, Bertics PJ and Paten TB (1999) Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J Biol Chem 274:14067-14073.
2. Boyd D (1996) Invasion and metastasis. Cancer Metastasis Rev 15:77-89.
3. Calleja R, Filloux C, Peraldi P, Baron V and Van Obberghen E (1997) The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase receptor. Endocrinology 138:1111-1120.
4. Chen T, Cho RW, Stork PJS and Weber MJ (1999) Elevation of cyclic adenosine 3′-5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 59:213-218.
5. Chen Z, Nield HS, Sun H, Barbier A and Patel TB (1995) Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J Biol Chem 270:27525-27530.
6. Cook SJ and McCormick F (1993) Inhibition by cAMP of ras-dependent activation of raf. Science (Wash DC) 282:1069-1072.
7. Daniel PB, Walker WH and Habener JF (1998) Cyclic AMP signaling and gene regulation. Annu Rev Nutr 18:353-383.
8. Gum R, Wang H, Lengyel E, Juarez J and Boyd D (1997) Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14:1481-1493.
9. Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel BJ (1997) Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14:1995-1998.
10. Hsueh YP and Lai MZ (1995) c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J Biol Chem 270:18094-18098.
11. Huang NN, Wang DJ and Heppel LA (1994) Role of adenosine 3′:5′-monophosphate-dependent protein kinase and cAMP levels in ATP-dependent mitogenesis in Swiss 3T3 cells. J Biol Chem 269:548-555.
12. Hudson LG and McCawley LJ (1998) Contributions of the EGF receptor to keratinocyte motility. Microsc Res Tech 43:444-455.
13. Iwamoto Y, Reich R, Nemeth G, Yamada Y and Martin GR (1993) Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts Clin Exp Metastasis 11:492-501.
14. Iwasaki T, Chen JD, Kim JP, Wynn KC and Woodley DT (1994) Dibutyryl cyclic AMP modulates keratinocyte migration without alteration of integrin expression. J Invest Dermatol 102:891-897.
15. Lampugnani MG, Giorgi M, Gaboli M, Dejana E and Marchisio PC (1990) Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Lab Invest 63:521-531.
16. Lauffenburger DA and Horwitz AF (1996) Cell migration: A physically integrated molecular process. Cell 84:359-369.
17. Lee, JC, Laydon, JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Keys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond) 372:739-746.
18. Li X, Yu H, Graves LM and Earp HS (1997) Protein kinase C and protein kinase A inhibit calcium-dependent but not stress-dependent c-Jun N-terminal kinase activation in rat liver epithelial cells. J Biol Chem 272:14996-15002
19. Marquez JA and Serrano R (1996) Multiple transduction pathways regulate the sodium-extrusion gene PMR2/ENA1 during salt stress in yeast. FEBS Lett 382:89-92.
20. McCawley LJ, O'Brien P and Hudson LG (1998) Epidermal growth factor (EGF) and scatter factor/hepatocyte growth factor (SF/HGF) mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176:255-265
21. McCawley LJ, Li S, Wattenberg EV and Hudson LG (1999) Sustained activation of the mitogen-activated protein kinase pathway: A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase -9 induction and cell migration. J Biol Chem 274:4347-4353.
22. Morton DM and Tchao R (1994) Regulation of motility and cytoskeletal organization of rat bladder carcinoma cells by cyclic AMP. Cell Motil Cytoskeleton 29:375-382.
23. Ogasawara M, Murata J, Ayukawa K and Saimi I (1997) Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Lett 116:111-116.
24. O'Neill C, Riddle P and Rozengurt E (1985) Stimulating the proliferation of quiescent 3T3 fibroblasts by peptide growth factors or by agents which elevate cellular cyclic AMP level has opposite effects on motility. Exp Cell Res 158:65-78.
25. Rao GN and Runge MS (1996) Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J Biol Chem 271:20805-20810.
26. Rodier JM, Valles AM, Denoyelle M, Thiery JP and Boyer B (1995) pp60c-src is a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line. J Cell Biol 131:761-773.
27. Sevetson BR, Kong X and Lawrence JC Jr (1993) Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90:10305-10309.
28. Shapiro PS, Evans JN, Davis RJ and Posada JA (1996) The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. J Biol Chem 271:5750-5754.
29. Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 10:602-608.
30. Siderius M, Rots E and Mager WH (1997) High-osmolarity signaling in Saccharomyces cerevisiae is modulated in a carbon-source-dependent fashion. Microbiology 143:3241-3250.
31. r 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 58:1135-1139.
32. Varela JC, Praekelt UM, Meacock PA, Planta RJ and Mager WH (1995) The Saccharomyces cerevisiae HSP12 gene is activated by the high-osmolarity glycerol pathway and negatively regulated by protein kinase A. Mol Cell Biol 15:6232-6245.
33. Welle A, Gupta K, Chang P, Swindle S, Glading A and Shiraha H (1998) Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech 43:395-411.
34. 1a melatonin receptor stably expressed in Chinese hamster ovary cells. Mol Pharmacol 50:166-179.
35. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science (Wash DC) 262:1065-1069.
36. Yao H, York RD, Misra-Press A. Carr DW and Stork PJ (1998) The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J Biol Chem 273:8240-8247.
37. Young MR, Duffie GP, Lozano Y, Young ME and Wright MA (1990) Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants. Cancer Res 50:2973-2978.
38. Young MR, Lozano Y, Djorjevic A and Maier GD (1993) Protein phosphatases limit tumor motility. Int J Cancer 54:1036-1041.
39. Zeigler ME, Chi Y, Schmidt T and Varani J (1999) Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180:271-284.